KEGG   PATHWAY: ko05416Help
Entry
ko05416                     Pathway                                

Name
Viral myocarditis
Description
Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.
Class
Human Diseases; Cardiovascular diseases
BRITE hierarchy
Pathway map
Viral myocarditis
ko05416

All organismsOrtholog table
Disease
H00295  
Viral myocarditis
Orthology
K06788  
coxsackievirus and adenovirus receptor
K04006  
decay accelerating factor
K05703  
tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06278  
caveolin 1
K06619  
abelson tyrosine-protein kinase 1 [EC:2.7.10.2]
K08887  
abelson tyrosine-protein kinase 2 [EC:2.7.10.2]
K04392  
Ras-related C3 botulinum toxin substrate 1
K07860  
Ras-related C3 botulinum toxin substrate 2
K07861  
Ras-related C3 botulinum toxin substrate 3
K12563  
delta-sarcoglycan
K12564  
gamma-sarcoglycan
K12565  
alpha-sarcoglycan
K12566  
beta-sarcoglycan
K06265  
dystroglycan 1
K10366  
dystrophin
K05692  
actin beta/gamma 1
K03260  
translation initiation factor 4G
K04503  
cyclin D1
K04398  
caspase 8 [EC:3.4.22.61]
K04726  
BH3 interacting domain death agonist
K08738  
cytochrome c
K04399  
caspase 9 [EC:3.4.22.62]
K02187  
caspase 3 [EC:3.4.22.56]
K10352  
myosin heavy chain
K03161  
tumor necrosis factor ligand superfamily member 5
K03160  
tumor necrosis factor receptor superfamily member 5
K06752  
major histocompatibility complex, class II
K10784  
T cell receptor alpha chain V region
K10785  
T-cell receptor beta chain V region
K06751  
major histocompatibility complex, class I
K05412  
CD80 antigen
K05413  
CD86 antigen
K06470  
CD28 antigen
K07818  
perforin 1
K05718  
integrin alpha L
K06464  
integrin beta 2
K06490  
intercellular adhesion molecule 1
K06856  
immunoglobulin heavy chain
Reference
  Authors
Esfandiarei M, McManus BM
  Title
Molecular biology and pathogenesis of viral myocarditis.
  Journal
Annu Rev Pathol 3:127-55 (2008)
Reference
  Authors
Badorff C, Knowlton KU
  Title
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
  Journal
Med Microbiol Immunol 193:121-6 (2004)
Reference
  Authors
Maekawa Y, Ouzounian M, Opavsky MA, Liu PP
  Title
Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
  Journal
Circulation 115:5-8 (2007)
Reference
  Authors
Pankuweit S, Portig I, Maisch B
  Title
Pathophysiology of cardiac inflammation: molecular mechanisms.
  Journal
Herz 27:669-76 (2002)
Reference
  Authors
Gao G, Luo H
  Title
The ubiquitin-proteasome pathway in viral infections.
  Journal
Can J Physiol Pharmacol 84:5-14 (2006)
Reference
  Authors
Coyne CB, Bergelson JM
  Title
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
  Journal
Cell 124:119-31 (2006)
Reference
  Authors
Badorff C, Lee GH, Knowlton KU
  Title
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
  Journal
Herz 25:227-32 (2000)
Reference
  Authors
Knowlton KU
  Title
CVB infection and mechanisms of viral cardiomyopathy.
  Journal
Curr Top Microbiol Immunol 323:315-35 (2008)
Reference
  Authors
Castellano G, Affuso F, Di Conza P, Fazio S
  Title
Myocarditis and dilated cardiomyopathy: possible connections and treatments.
  Journal
J Cardiovasc Med (Hagerstown) 9:666-71 (2008)
Reference
  Authors
Cooper LT Jr
  Title
Myocarditis.
  Journal
N Engl J Med 360:1526-38 (2009)
Reference
  Authors
Kawai C
  Title
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
  Journal
Circulation 99:1091-100 (1999)
Reference
  Authors
Liu PP, Mason JW
  Title
Advances in the understanding of myocarditis.
  Journal
Circulation 104:1076-82 (2001)
Reference
  Authors
Mason JW
  Title
Myocarditis and dilated cardiomyopathy: an inflammatory link.
  Journal
Cardiovasc Res 60:5-10 (2003)
Reference
  Authors
Tam PE
  Title
Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
  Journal
Viral Immunol 19:133-46 (2006)

DBGET integrated database retrieval system